The underlying molecule, semaglutide 2.4 mg, is one of the most-studied weight-loss medications in history: in the STEP 1 trial (n = 1,961), adults lost an average of 14.9% of body weight over 68 weeks vs 2.4% on placebo (NEJM 2021, DOI 10.1056/NEJMoa2032183)
If you are still getting oriented to how any of this works, what peptide therapy is covers the fundamentals, and the peptide side effects guide explains what is common versus what deserves a call to your provider
However, we did find in ME/CFS raised lactate concentrations in both pgACC and dACC, and in long COVID, decreased concentrations of total choline in dACC, compared to healthy controls
Using a vial more than once significantly increases the risk of bacterial contamination and infection, and you may not receive the correct amount of medication
When semaglutide is chosen thoughtfully and supported by experienced medical guidance, it can be more than a trend it can be the start of a healthier, more confident chapter.
